For copyright status please check original publication.
Citation
NIH, 2014. Prospective Grant of an Exclusive Evaluation License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers, National Institutes of Health.
United States of America
Retrieved from https://coilink.org/20.500.12592/gdfqkg on 18 Nov 2024. COI: 20.500.12592/gdfqkg.
If your institution is a member, please log into
Applied Science Commons from a link provided by your institution. This typically
involves logging in via a menu managed by your library.
If your institution is a member, please log into Policy
Commons from a link provided by your institution. This typically involves
logging in via a menu managed by your library.
20.500.12592/vd4zqk